Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases

LP Jordheim, D Durantel, F Zoulim… - Nature reviews Drug …, 2013 - nature.com
Nucleoside analogues have been in clinical use for almost 50 years and have become
cornerstones of treatment for patients with cancer or viral infections. The approval of several …

Lipid–drug conjugate for enhancing drug delivery

D Irby, C Du, F Li - Molecular pharmaceutics, 2017 - ACS Publications
Lipid–drug conjugates (LDCs) are drug molecules that have been covalently modified with
lipids. The conjugation of lipids to drug molecules increases lipophilicity and also changes …

Lyotropic liquid crystal engineering–ordered nanostructured small molecule amphiphile self-assembly materials by design

C Fong, T Le, CJ Drummond - Chemical Society Reviews, 2012 - pubs.rsc.org
Future nanoscale soft matter design will be guided to a large extent by the teachings of
amphiphile (lipid or surfactant) self-assembly. Ordered nanostructured lyotropic liquid …

Triterpenes as potentially cytotoxic compounds

M Chudzik, I Korzonek-Szlacheta, W Król - Molecules, 2015 - mdpi.com
Triterpenes are compounds of natural origin, which have numerously biological activities:
anti-cancer properties, anti-inflammatory, anti-oxidative, anti-viral, anti-bacterial and anti …

Recent advances and prospects in gemcitabine drug delivery systems

S Paroha, J Verma, RD Dubey, RP Dewangan… - International Journal of …, 2021 - Elsevier
Cancer is a community health hazard which progress at a fatal rate in various countries
across the globe. An agent used for chemotherapy should exhibit ideal properties to be an …

Nanomedicine to target multidrug resistant tumors

E Lepeltier, P Rijo, F Rizzolio, R Popovtzer… - Drug Resistance …, 2020 - Elsevier
Nanomedicine employs nanotechnologies to develop innovative applications, and more
specifically nano-objects in the field of human health, through exploitation of the physical …

Self-assembled lipid–prodrug nanoparticles

P Couvreur, S Lepetre-Mouelhi, E Garbayo… - Nature Reviews …, 2023 - nature.com
Nanomedicines suffer from poor drug loading and uncontrolled 'burst release'after
administration. Combining prodrug strategies with nanostructured carriers can help to …

Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery

D Sobot, S Mura, SO Yesylevskyy, L Dalbin… - Nature …, 2017 - nature.com
Once introduced in the organism, the interaction of nanoparticles with various biomolecules
strongly impacts their fate. Here we show that nanoparticles made of the squalene derivative …

Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics

JL Arias, LH Reddy, M Othman, B Gillet, D Desmaele… - ACS …, 2011 - ACS Publications
This study reports the design of a novel theragnostic nanomedicine which combines (i) the
ability to target a prodrug of gemcitabine to an experimental solid tumor under the influence …

Squalenoylation: a generic platform for nanoparticular drug delivery

D Desmaële, R Gref, P Couvreur - Journal of controlled release, 2012 - Elsevier
Squalene is a triterpene widely distributed in nature that is an intermediate in the cholesterol
biosynthesis pathway. The remarkable dynamic folded conformation of squalene has been …